Considerations for Return to Exercise following Mild-to-Moderate COVID-19 in the Recreational Athlete

被引:24
|
作者
Metzl, Jordan D. [1 ]
McElheny, Kathryn [1 ]
Robinson, James N. [1 ]
Scott, Daphne A. [1 ]
Sutton, Karen M. [1 ]
Toresdahl, Brett G. [1 ]
机构
[1] Hosp Special Surg, Sports Med Inst, 535 70th St, New York, NY 10021 USA
关键词
COVID-19; activity; exercise; recreational athlete; CORONAVIRUS DISEASE 2019; ONE-YEAR OUTCOMES; CLINICAL CHARACTERISTICS; SURVIVORS;
D O I
10.1007/s11420-020-09777-1
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
The COVID-19 pandemic has resulted in significant morbidity and mortality around the world. The spectrum of COVID-19 is broad, from clinical disease requiring intensive medical care to less severe symptoms that are treated with supportive care. The majority of COVID-19 cases fall into the mild-to-moderate category, with symptoms lasting less than 6 weeks. Nevertheless, the morbidity from COVID-19 is significant and can affect multiple body systems, most frequently the cardiac, pulmonary, hematologic, musculoskeletal, and gastrointestinal systems. For patients who wish to return to exercise after mild-to-moderate COVID-19, the wide range of disease expression presents a challenge for clinicians seeking to offer counsel. This literature review on return to activity following mild to moderate COVID-19 in the recreational athlete includes evidence-based considerations and recommendations for clinicians in guiding the safest return to activity.
引用
收藏
页码:102 / 107
页数:6
相关论文
共 50 条
  • [1] Azithromycin for mild-to-moderate COVID-19
    Patel, Jigar
    Berezowski, Ivan
    Abdelmonem, Ahmed
    Taylor, Dania
    Pourmand, Ali
    [J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (10): : E99 - E99
  • [2] Integrative medicine considerations for convalescence from mild-to-moderate COVID-19 disease
    Alschuler, Lise
    Chiasson, Ann Marie
    Horwitz, Randy
    Sternberg, Esther
    Crocker, Robert
    Weil, Andrew
    Maizes, Victoria
    [J]. EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2022, 18 (02) : 140 - 148
  • [3] Mild-to-Moderate COVID-19 Infection and Myocarditis: A Review
    Bailey, Eric
    Frishman, William H. H.
    [J]. CARDIOLOGY IN REVIEW, 2023, 31 (03) : 173 - 175
  • [4] Features of Mild-to-Moderate COVID-19 Patients With Dysphonia
    Lechien, Jerome R.
    Chiesa-Estomba, Carlos M.
    Cabaraux, Pierre
    Mat, Quentin
    Huet, Kathy
    Harmegnies, Bernard
    Horoi, Mihaela
    Le Bon, Serge Daniel
    Rodriguez, Alexandra
    Dequanter, Didier
    Hans, Stephane
    Crevier-Buchman, Lise
    Hochet, Baptiste
    Distinguin, Lea
    Chekkoury-Idrissi, Younes
    Circiu, Marta
    El Afia, Fahd
    Barillari, Maria Rosaria
    Cammaroto, Giovanni
    Fakhry, Nicolas
    Michel, Justin
    Radulesco, Thomas
    Martiny, Delphine
    Lavigne, Philippe
    Jouffe, Lionel
    Descamps, Geraldine
    Journe, Fabrice
    Trecca, Eleonora M. C.
    Hsieh, Julien
    Delgado, Irene Lopez
    Calvo-Henriquez, Christian
    Vergez, Sebastien
    Khalife, Mohamad
    Molteni, Gabriele
    Mannelli, Giuditta
    Cantarella, Giovanna
    Tucciarone, Manuel
    Souchay, Christel
    Leich, Pierre
    Ayad, Tareck
    Saussez, Sven
    [J]. JOURNAL OF VOICE, 2022, 36 (02) : 249 - 255
  • [5] Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
    Cavalcanti, A. B.
    Zampieri, F. G.
    Rosa, R. G.
    Azevedo, L. C. P.
    Veiga, V. C.
    Avezum, A.
    Damiani, L. P.
    Marcadenti, A.
    Kawano-Dourado, L.
    Lisboa, T.
    Junqueira, D. L. M.
    de Barros e Silva, P. G. M.
    Tramujas, L.
    Abreu-Silva, E. O.
    Laranjeira, L. N.
    Soares, A. T.
    Echenique, L. S.
    Pereira, A. J.
    Freitas, F. G. R.
    Gebara, O. C. E.
    Dantas, V. C. S.
    Furtado, R. H. M.
    Milan, E. P.
    Golin, N. A.
    Cardoso, F. F.
    Maia, I. S.
    Hoffmann Filho, C. R.
    Kormann, A. P. M.
    Amazonas, R. B.
    Bocchi de Oliveira, M. F.
    Serpa-Neto, A.
    Falavigna, M.
    Lopes, R. D.
    Machado, F. R.
    Berwanger, O.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (21): : 2041 - 2052
  • [6] Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19
    Moser, Carlee B.
    Li, Jonathan Z.
    Hughes, Michael D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (16): : 1533 - 1535
  • [7] Mild-to-Moderate Croup Presentations in Patients With COVID-19 Infection
    Mathew, Danica
    Calderon, Jose Cucalon
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [8] Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19
    Cao, Bin
    Wang, Yeming
    Lu, Hongzhou
    Huang, Chaolin
    Yang, Yumei
    Shang, Lianhan
    Chen, Zhu
    Jiang, Rongmeng
    Liu, Yihe
    Lin, Ling
    Peng, Ping
    Wang, Fuxiang
    Gong, Fengyun
    Hu, Honglin
    Cheng, Cong
    Yao, Xiangyang
    Ye, Xianwei
    Zhou, Hourong
    Shen, Yinzhong
    Liu, Chenfan
    Wang, Chunying
    Yi, Zhennan
    Hu, Bijie
    Xu, Jiuyang
    Gu, Xiaoying
    Shen, Jingshan
    Xu, Yechun
    Zhang, Leike
    Fan, Jia
    Tang, Renhong
    Wang, Chen
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (03): : 230 - 241
  • [9] Oral Probenecid for Nonhospitalized Adults with Symptomatic Mild-to-Moderate COVID-19
    Martin, David E.
    Pandey, Neelam
    Chavda, Purvi
    Singh, Gurpreet
    Sutariya, Rakesh
    Sancilio, Frederic
    Tripp, Ralph A.
    [J]. VIRUSES-BASEL, 2023, 15 (07):
  • [10] Organ-Dysfunction Markers in Mild-to-Moderate COVID-19 Convalescents
    Wisniewska, Aleksandra
    Kijak, Aleksandra
    Nowak, Karolina
    Lulek, Michalina
    Skwarek, Agata
    Malecka-Gieldowska, Milena
    Smiarowski, Marcin
    Wasik, Szczepan
    Ciepiela, Olga
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)